Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de pointes in models of acquired and congenital long QT syndrome

Citation
W. Shimizu et al., Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de pointes in models of acquired and congenital long QT syndrome, J CARD ELEC, 10(2), 1999, pp. 154-164
Citations number
37
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
ISSN journal
10453873 → ACNP
Volume
10
Issue
2
Year of publication
1999
Pages
154 - 164
Database
ISI
SICI code
1045-3873(199902)10:2<154:SPRTDO>2.0.ZU;2-E
Abstract
Electrophysiologic Effects of Pentobarbital, Introduction: Sodium pentobarb ital is widely used for anesthesia in experimental studies as well as in cl inics, and it is known to prevent the development of torsades de pointes (T dP) in in vivo models of the long QT syndrome (LQTS). Methods and Results: This study examines the effects of pentobarbital on tr ansmural dispersion of repolarization (TDR) and induction of TdP in arteria lly perfused canine left ventricular wedge preparations in which transmembr ane action potentials were simultaneously recorded from epicardial, M, and endocardial regions using floating glass microelectrodes together with a tr ansmural EGG. d-Sotalol and ATX-II were used to mimic the LQT2 and LQT3 for ms of congenital LOTS. Both d-sotalol (100 mu mol/L, n = 6) and ATX-II (20 nmol/L, n = 6) preferentially prolonged the action potential duration (APD( 90)) of the M cell, thus increasing in the QT interval and TDR, and leading to the development of spontaneous and stimulation-induced TdP. In the abse nce and presence of d-sotalol, pentobarbital (10, 20, and 50 mu g/mL) prolo nged the APD(90) of epicardial and endocardial cells, and, to a lesser exte nt, that of the M cell, thus prolonging the QT interval but reducing TDR. I n the ATX-II model, the effects of pentobarbital on the QT interval and APD (90) were biphasic: 10 mu g/mL pentobarbital further prolonged APD(90) of e picardial and endocardial cells more than that of the M cell; 20 to 50 mu g /mL pentobarbital abbreviated the APD(90) of epicardial and endocardial cel ls less than that of the M cell, thus abbreviating the QT interval and mark edly reducing TDR. Twenty to 50 mu g/mL pentobarbital totally suppressed sp ontaneous as well as stimulation-induced TdP in both models. Conclusion: Our data indicate that pentobarbital reduces TDR in control and under conditions of congenital and acquired LOTS, and suggest that this me chanism may contribute to the ability of the anesthetic to prevent the deve lopment of spontaneous as well as stimulation-induced TdP under conditions mimicking LQT2, LQT3, and acquired (drug-induced) forms of the LOTS. The da ta also serve to illustrate that there are circumstances under which QT pro longation may not be arrhythmogenic.